资讯

Fiscal Q4 Net Income up 176% to $3.4 million; Adjusted EBITDA up 7% to $8.6 million –HOUSTON, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Evolution ...
Cytokinetics, Incorporated (“Cytokinetics”) (Nasdaq: CYTK) today announced its intention to offer, subject to market ...